$BG

Bunge Global SA

CIK:0001996862|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Net sales	$ 24,041	$ 12,769	$ 45,902	$ 24,412
Cost of goods sold	(22,360)	(12,031)	(43,455)	(23,077)
Gross profit	1,681	738	2,447	1,335
Selling, general and administrative expenses	(606)	(418)	(1,137)	(798)
Interest income	43	46	88	105
Interest expense	(197)	(106)	(378)	(210)
Foreign exchange gains (losses) – net	(26)	44	(120)	69
Other income (expense) – net	39	187	92	269
Income (loss) from affiliates	9	3	12	8
Income (loss) before income tax	943	494	1,004	778
Income tax (expense) benefit	(236)	(124)	(222)	(204)
Net income (loss)	707	370	782	574
Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests	(29)	(16)	(36)	(19)
Net income (loss) attributable to Bunge shareholders (Note 18)	$ 678	$ 354	$ 746	$ 555
Earnings per share—basic (Note 18)
Net income (loss) attributable to Bunge shareholders - basic (in dollars per share)	$ 3.50	$ 2.63	$ 3.85	$ 4.14
Earnings per share—diluted (Note 18)
Net income (loss) attributable to Bunge shareholders - diluted (in dollars per share)	$ 3.47	$ 2.61	$ 3.81	$ 4.10

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
OPERATING ACTIVITIES
Net income (loss)	$ 782	$ 574
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:
Foreign exchange (gain) loss on net debt	(98)	(208)
Depreciation, depletion and amortization	494	236
Share-based compensation expense	53	35
Deferred income tax expense (benefit)	(20)	20
(Gain) loss on sale of investments and property, plant and equipment	(6)	(148)
Results from affiliates	(19)	(8)
Dividend return on investment	47	29
Other, net	73	58
Changes in operating assets and liabilities, excluding the effects of acquisitions and dispositions:
Trade accounts receivable	35	(110)
Inventories	(2,235)	(1,261)
Secured advances to suppliers	(257)	(254)
Trade accounts payable and accrued liabilities	344	(55)
Advances on sales	(201)	(107)
Net unrealized (gains) losses on derivative contracts	93	(120)
Margin deposits	(155)	(59)
Recoverable and income taxes, net	87	71
Marketable securities	(1)	16
Other, net	(142)	(66)
Cash provided by (used for) operating activities	(1,126)	(1,357)
INVESTING ACTIVITIES
Payments made for capital expenditures	(779)	(716)
Acquisitions of businesses (net of cash acquired)	(105)	0
Proceeds from investments	1,275	850
Payments for investments	(654)	(783)
Settlements of net investment hedges	(8)	(27)
Proceeds from disposal of business and property, plant and equipment	14	472
Proceeds from sale of investments in affiliates	0	100
Payments for investments in affiliates	(49)	(63)
Other, net	31	65
Cash provided by (used for) investing activities	(275)	(102)
FINANCING ACTIVITIES
Net change in short-term debt with maturities of three months or less	702	2,704
Proceeds from short-term debt with maturities greater than three months	1,292	670
Repayments of short-term debt with maturities greater than three months	(1,291)	(710)
Proceeds from long-term debt	1,198	2,303
Repayments of long-term debt	(628)	(57)
Repurchases of registered shares	(249)	0
Dividends paid to registered shareholders	(275)	(185)
Capital contributions from (Return of capital to) noncontrolling interest	16	30
Sale of redeemable noncontrolling interest	80	206
Acquisition of noncontrolling interest	0	(18)
Other, net	(13)	(5)
Cash provided by (used for) financing activities	832	4,938
Effect of exchange rate changes on cash and cash equivalents, and restricted cash	(1)	5
Net increase (decrease) in cash and cash equivalents, and restricted cash	(570)	3,484
Cash and cash equivalents, and restricted cash - beginning of period	1,166	3,328
Cash and cash equivalents, and restricted cash - end of period	$ 596	$ 6,812

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 593	$ 1,135
Time deposits under trade structured finance program (Note 3)	45	208
Trade accounts receivable (net of allowances of $161 and $156) (Note 4)	3,931	3,870
Inventories (Note 5)	15,461	13,198
Assets held for sale (Note 2)	312	191
Other current assets (Note 6)	5,873	5,789
Total current assets	26,215	24,391
Property, plant and equipment, net	11,945	11,678
Operating lease assets	1,707	1,686
Goodwill	3,354	3,141
Other intangible assets, net	288	309
Investments in affiliates	1,307	1,495
Deferred income taxes	902	890
Other non-current assets (Note 7)	1,064	938
Total assets	46,782	44,528
Current liabilities:
Short-term debt (Note 13)	4,588	3,883
Current portion of long-term debt (Note 13)	1,200	1,337
Letter of credit obligations under trade structured finance program (Note 3)	45	208
Trade accounts payable (includes $874 and $559 carried at fair value) (Note 11)	5,370	4,881
Current operating lease obligations	502	499
Liabilities held for sale (Note 2)	87	61
Other current liabilities (Note 10)	4,942	4,258
Total current liabilities	16,734	15,127
Long-term debt (Note 13)	9,426	8,831
Deferred income taxes	931	988
Non-current operating lease obligations	1,096	1,097
Other non-current liabilities (Note 16)	1,185	1,063
Redeemable noncontrolling interest	68	53
Equity (Note 17):
Registered shares, par value $0.01; authorized not issued – 33,632,445 shares; conditionally authorized 32,285,894 shares; issued and outstanding: 2026 – 192,106,786 shares, 2025 – 193,408,656 shares	2	2
Additional paid-in capital	9,838	9,841
Retained earnings	13,339	13,152
Accumulated other comprehensive income (loss) (Note 17)	(6,014)	(6,084)
Treasury shares, at cost; 2026 - 16,404,977 shares and 2025 - 15,103,107 shares	(1,212)	(1,007)
Total Bunge shareholders’ equity	15,953	15,904
Noncontrolling interests	1,389	1,465
Total equity	17,342	17,369
Total liabilities, redeemable noncontrolling interest and equity	$ 46,782	$ 44,528